Pharma & Life Sciences SMB (51-200 employees)

Regulatory Affairs Specialist at SMB

High Conscientiousness and Openness to manage registration dossiers, engage regulatory agencies, and anticipate regulatory changes across LATAM.

In SMB pharma, quality and compliance are the license to operate

The development pipeline is the company's valuation and main asset

The relationship with local health authorities is capital built over years

Generic profile Startup (1-50 employees) Enterprise (201-1000 employees) Global (1001+ employees)

Ideal OCEAN+ Profile

Ideal range

Openness

70 85

At SMBs (51-200 employees), ability to interpret complex regulations, identify precedents, and design registration strategies in response to regulatory changes across LATAM

Conscientiousness

80 92

At SMBs (51-200 employees), absolute precision in preparing dossiers, tracking regulatory deadlines, and keeping registration documentation current

Extraversion

51 68

At SMBs (51-200 employees), ability to engage with regulatory authorities and represent the company's position before agencies such as COFEPRIS, ANMAT, or ANVISA

Agreeableness

55 70

At SMBs (51-200 employees), collaboration with quality, medical, legal, and marketing teams to align registration strategies with business needs

Emotional Stability

73 87

At SMBs (51-200 employees), managing stress under immovable regulatory deadlines, agency queries, and the risk of product unavailability

Structure & Rhythm

85 95

At SMBs (51-200 employees), regulatory Affairs operates on defined submission procedures, ICH/FDA/EMA guidelines, and agency response timelines; any deviation from the submission process can result in rejection, delay, or regulatory sanction

Strengths and Red Flags

Strengths

Preparing and managing registration dossiers with a high first-round approval rate
Interpreting local and international regulations (ICH, CTD, eCTD)
Managing development pipelines balancing innovation with commercial viability
GMP and regulatory compliance with limited internal quality teams

Red Flags

Superficial dossier review that generates avoidable agency queries
Regulatory knowledge gaps that lead to strategies based on outdated rules
Difficulty maintaining compliance with limited quality resources
Resists outsourcing activities it can't perform internally

Interview Questions

What was the most complex registration dossier you prepared? What queries did you get from the agency, and how did you respond to them?

Evaluates: Conscientiousness and handling complex regulatory interactions

Describe how you monitor regulatory changes in the countries in your portfolio. Give me an example of a recent change you anticipated and how it affected the business.

Evaluates: Openness and proactive regulatory intelligence

How did you maintain GMP compliance with limited quality teams?

Evaluates: Conscientiousness and efficiency in quality management

How did you balance innovation with commercial viability in your pipeline?

Evaluates: Balance between scientific rigor and business pragmatism